A great advance in autism research: the importance of immunocal
- Glutation en Espanol
- Feb 26, 2024
- 2 min read
Did you know that Immunocal has a patent request for compositions and methods to help the autistic spectrum disorder? A great achievement in autism research and promising development for people and families affected by this neurodevelopmental disorder.
Decoding the study: the impact of immunocal on autistic spectrum disorder
The autistic spectrum disorder affects 1 in 54 children only in the United States, and the figures are increasing. Conventional medical treatments have had a limited impact on the improvement of the disorder, which has led to the exploration of new therapies and treatments. Recent investigations have discovered that many autistic have an increase in oxidative stress markers and mitochondrial dysfunction, a decrease in glutathione levels and genetic anomalies in the glutathione route. This has led to the hypothesis that a nutritional supplement based on whey protein rich in cysteine that serves as glutathione precursors can improve behavioral function in children with autism.
The Universidad Nova Southeastern de Florida conducted a study in which the effects of our exclusive serum protein isolate formula rich in cysteine in preschool children with autism, and the results were revolutionary were evaluated.
60 children participated in the study, 20 of which were randomly assigned to Immunocal treatment for three months and 20 to a control group that received rice protein. Before and after treatment, fundamental areas of autistic behavior were evaluated, such as atypical behaviors, communication, development status and behavioral problems. Blood glutathione levels were also quantified before and after treatment.
The results showed that the children who received Immunocal demonstrated significant improvements in their behavioral function compared to the control group. It was also found that blood glutathione levels increased in the group that consumed immunocal.
April is the month of awareness about autism!
“Improving the quality of life of children with autism was a plus. This April, let's work together to create a more comprehensive and useful world for people with autism. Together we can knock down barriers and encourage inclusion. ” CEO, Mauricio Domenzain
“When celebrating this month, it is important to continue exploring new treatments and therapies for people with autism and support ongoing research in this area. Let's help by sharing and demonstrating our support. With continuous research and the exploration of new treatments and therapies, we can help make a difference in the lives of families around the world. ” Dr. Jimmy Gutman President of the Scientific Advice and Global Authority Council in glutathione.
Join us to support the month of awareness of autism and the important research that was carried out in NSU on the effects of immunocal on children with ASD. Together, we can make a difference
Sources:
+ Registration of Clinical Tests: https://clinicaltrials.gov/ct2/show/study/nct01366859 Identifier: NCT01366859
+ PMCID: PMC8514994
+ United States Patent Request No. 16/634,946 presented on July 31, 2018
"Compositions and methods for the treatment of autistic spectrum disorder"
*These statements have not been evaluated by the Food and Drug Administration. Our products are not intended to diagnose, treat, cure or prevent any disease. This post is intended for the US market.
Comments